This article in The Telegraph, 22 July 2015, explores how “health service officials earn thousands organising and attending extravagant events where companies promote their products.
. . .
There have been concerns for a number of years. In 2013, the Association of the British Pharmaceutical Industry claimed that both NHS and private staff were paid £40 million for consultancies and sponsorships and other interactions with drug businesses.”
Does this only happen in the UK?
Read the article at:
Of course if a product such as compounded bioidentical hormones cannot be patented, it will not be included in such marketing drives and of course it does not make money for drug companies . . .